The new Eurosurveillance website is almost here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2016: Volume 21/ Issue 8 Article 2
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 21, Issue 8, 25 February 2016
Rapid communication
Grami, Mansour, Mehri, Bouallègue, Boujaâfar, Madec, and Haenni: Impact of food animal trade on the spread of mcr-1-mediated colistin resistance, Tunisia, July 2015

+ Author affiliations

Citation style for this article: Grami R, Mansour W, Mehri W, Bouallègue O, Boujaâfar N, Madec J, Haenni M. Impact of food animal trade on the spread of mcr-1-mediated colistin resistance, Tunisia, July 2015. Euro Surveill. 2016;21(8):pii=30144. DOI:

Received:08 February 2016; Accepted:25 February 2016

Horizontal transfer was found to play a major role in the spread of colistin resistance in Enterobacteriaceae when a plasmid-located mcr-1 gene was reported to be circulating in livestock, foodstuff and human beings in China in late 2015 [1]. A few weeks later, mcr-1 was recognised in Europe among extended-spectrum beta-lactamase (ESBL)- or AmpC-producing Escherichia coli isolated from chicken meat and humans [2]. In January 2016, the worldwide distribution of the mcr-1 gene was highlighted [3,4].

The plasmid type first identified as a mcr-1 vehicle in China was an IncI2-like plasmid, but several different mcr-1-positive plasmids have now been reported, including IncHI2-type plasmids. Indeed, Tse et al. reported mcr-1 on an IncHI2-type plasmid in a Salmonella enterica isolate from a food sample in Portugal in 2011 [5]. Interestingly, IncHI2-type plasmids were also recognised to spread blaCTX-M-1 and mcr-1 in E. coli in food animals in France [6]. These data suggest a specific epidemiology of mcr-1 plasmids in the European animal reservoir that pose a risk for humans. This prompted us to investigate 37 E. coli strains recovered from 29 Tunisian chickens imported from France or derived from French imported chicks and harbouring resistance to colistin and broad-spectrum cephalosporins.

Detection of the blaCTX-M-1 and mcr-1 genes in healthy chickens in Tunisia

In July 2015, 52 randomly chosen healthy birds were collected on three different Tunisian farms: 10 on farm A, 12 on farm B and 30 on farm C with the initial purpose to investigate the prevalence of ESBL-positive chickens. A faecal sample of each individual was plated on MacConkey agar containing 4 mg/L cefotaxime and one colony per morphology was picked up. This resulted in the identification of 37 E. coli isolates harbouring resistance to broad-spectrum cephalosporins and originating from 29 birds (Table).


Epidemiological and molecular features of blaCTX-M-1/mcr-1-positive Escherichia coli, Tunisia, July 2015 (n = 37)

Farm Location Number of birds on farm Age of birds Origin of the birds Number of birds sampled Number of ESBL-positive birds Number of mcr‑1 and blaCTX‑M‑1-positive E. coli Plasmid type carrying blaCTX‑M‑1 and mcr‑1
Farm A Moknine 8,500 17–18 weeks France 10 2 2 IncHI2/ST4
Farm B Enfidha 200,000 35 days Tunisia/France 12 2 2 IncHI2/ST4
Farm C Moknine 7,500 62 weeks France 30 25 33a IncHI2/ST4

ESBL: extended-spectrum beta-lactamase.

a One colony per morphology was picked up, resulting in a higher number of E. coli isolates than the number of samples.

Those 29 birds were from farm A (2/10), farm B (2/12) and farm C (25/30). All 37 isolates produced an ESBL as attested by the synergy test, and the blaCTX-M-1 gene was identified in all isolates by PCR and sequencing. All isolates expressed additional co-resistances to phenicols, tetracyclines, sulfonamides, trimethoprim, quinolones and fluoroquinolones as determined by disk diffusion against 32 antibiotics. Surprisingly, disk diffusion also revealed small colistin diameters (16–17 mm). We were in the course of investigating these non-susceptible isolates when the publication by Liu et al. [1] drew a different light on our results and prompted us to further investigate colistin resistance.

All isolates presented a minimum inhibitory concentration (MIC) of 2–6 μg/mL to colistin by E-test. PCR and sequencing using published primers [1] revealed the newly described mcr-1 gene in all of the ESBL-positive E. coli with 100% homology to the published sequence (GenBank: KP347127.1). Isolates from farm A presented two closely related but not identical XbaI pulsed-field gel electrophoresis (PFGE) patterns (one band difference) belonging to cluster G, while isolates from farm B presented two distinct patterns belonging to the clusters F and K (Figure 1).

Figure 1

Pulsed-field gel electrophoresis-based dendrogram and XbaI macrorestrictions, Tunisia, July 2015 (n = 37)


MIC: minimum inhibitory concentration; PFGE: pulsed-field gel electrophoresis.

Analysis was performed using the Dice coefficient with optimisation set at 0.5% and tolerance at 1.5%.

Isolates from farm C presented one main cluster (cluster D encompassing 17 isolates presenting patterns with > 90% similarity) and nine additional clusters (A–C, E, H–L) presenting patterns with < 90% similarity. Antibiotics used were colistin, sulfonamides and enrofloxacin on farms A and C, and chloramphenicol and enrofloxacin on farm B.

Co-localisation of blaCTX-M-1 and mcr-1 on IncHI2-type plasmids

Replicon typing and hybridisation experiments proved that blaCTX-M-1 and mcr-1 co-localised in all isolates on a single and large (250–280 kbp) IncHI2-type plasmid (Figure 2).

Figure 2

Southern blot hybridisations on S1 nuclease-pulsed-field gel electrophoresis gels using specific probes for the detection of blaCTX-M-1, IncHI2 and mcr-1, Tunisia, July 2015 (n = 10)


PFGE: pulsed-field gel electrophoresis

M: size marker (Lambda ladder 0.05-1 Mb, Bio-Rad); Lane 1: isolate MF5; Lane 2: isolate MF8; Lane 3: isolate 10; Lane 4: isolate 12; Lane 5: isolate 14; Lane 6: isolate 16A; Lane 7: isolate 16B; Lane 8: isolate 18A; Lane 9: isolate 21A; Lane 10: isolate 24B.

All 37 isolates presented the same profile, so that only a subset of 10 isolates is presented here.

According to the plasmid double locus sequence typing (pDLST) scheme [7], these IncHI2-type plasmids belonged to the ST4 subtype and presented positive amplification of the hipA gene and no amplification of the smr092 and smr0183 genes [7]. Interestingly, the IncHI2-type plasmids recently found in food animals in France also belonged to the very same ST4 subtype (data not shown) [6]. Hence, IncHI2-type plasmids were responsible for the spread of blaCTX-M-1 and mcr-1 in different chicken farms in Tunisia, in the bovine sector in France and in foodstuff in Portugal.

High prevalence of mcr-1-positive chickens on Tunisian farms

Data on mcr-1 from the poultry reservoir are lacking except for one single case in Algeria [8]. However, mcr-1 reports from chicken meat have been recurrent [1,2,9,10]. Here, farms A and C (counting 7,500 and 8,500 chickens, respectively) host grandparent flocks and import one-day-old chicks from France (Table). Farm B is located 80 km apart from the others and rears 200,000 broilers deriving from one-day-old chicks sold by a Tunisian hatchery also importing birds from France. Thus, the estimated true prevalence (with confidence intervals at 95%) of mcr-1-positive chickens reaches 20% (3–56%) on farm A, 17% (4–49%) on farm B and 83% (65–94%) on farm C. This last figure is even higher than recently reported from food animals in China [1].


From this study, we conclude that the live chicken population in Tunisia is heavily colonised by mcr-1-positive E. coli with subsequent possible contamination of chicken products [11,12]. Multilocus sequence typing (MLST) was not performed in this study since PFGE demonstrated the presence of numerous clusters of E. coli (A to L) so that the mcr-1 dissemination was clearly a consequence of the spread of the unique IncHI2/ST4 plasmid in various E. coli backgrounds.

Contamination of both the poultry production pyramid and the food chain is undoubtedly of public health relevance. It is now crucial to determine the prevalence of the mcr-1 gene in poultry and poultry meat as well as in other livestock (live animals or meat) in Tunisia and other African countries in order to estimate the risk to human health.

In addition, the finding of a single IncHI2-type plasmid spreading the blaCTX-M-1/mcr-1 genes in the food sector in different European and non-European countries makes us believe that global imports and exports of food animals and foodstuff are a major determinant of mcr-1 dissemination. Global chicken meat production is forecast to dramatically increase in the future because of rising demands worldwide and subsequent rising production volumes in the major exporting countries. European countries already faced a major spread of ESBL/pAmpC genes in animals that subsequently became ESBL sources for humans, mostly as a result of poultry trades [13,14]. Worryingly, genes providing resistance to broad-spectrum cephalosporins and colistin have been shown to be tightly linked on the same plasmids, indicating that urgent international attention is necessary on the global market of veterinary drugs for food animals.


This work was supported by the Agency for Food, Environmental and Occupational Health and Safety (ANSES) and by a grant of the ANIWHA ERA-NET project (France). Raoudha Grami has a fellowship from the Region Rhône-Alpes (Accueil Doc, CMIRA 2011), from the Ministère de l’Enseignement Supérieur et de la Recherche Scientifique in Tunisia and from the Agence Campus France (Agence française pour la promotion de l'enseignement supérieur, l'accueil et la mobilité internationale).

We thank Emilie Gay for her help with the statistics.

Conflict of interest

None declared.

Authors’ contributions

RG collected the isolates, collected the data and performed the molecular analysis. MH, WM, and JYM coordinated the work and participated to the data analysis. MH and JYM drafted the manuscript, WM and RG participated in the writing of the manuscript, and all authors have read and accepted the submitted manuscript.


  1. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J,  et al.  Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161-8. DOI: 10.1016/S1473-3099(15)00424-7 PMID: 26603172

  2. Hasman H, Hammerum AM, Hansen F, Hendriksen RS, Olesen B, Agersø Y,  et al.  Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill. 2015;20(49):30085. DOI: 10.2807/1560-7917.ES.2015.20.49.30085 PMID: 26676364

  3. Suzuki S, Ohnishi M, Kawanishi M, Akiba M, Kuroda M. Investigation of a plasmid genome database for colistin-resistance gene mcr-1. Lancet Infect Dis. 2016.pii: S1473-3099(16)00008-6. 10.1016/S1473-3099(16)00008-6 .

  4. Malhotra-Kumar S, Xavier BB, Das AJ, Lammens C, Hoang HT, Pham NT, et al. Colistin-resistant Escherichia coli harbouring mcr-1 isolated from food animals in Hanoi, Vietnam. Lancet Infect Dis. 2016.pii: S1473-3099(16)00014-1. 10.1016/S1473-3099(16)00014-1 .

  5. Tse H, Yuen K-Y. Dissemination of the mcr-1 colistin resistance gene.Lancet Infect Dis. 2016;16(2):145-6. DOI: 10.1016/S1473-3099(15)00532-0 PMID: 26711362

  6. Haenni M, Poirel L, Kieffer N, Châtre P, Saras E, Métayer V, et al. Co-occurrence of ESBL and MCR-1 encoding genes on plasmids: a further step towards a pandemic spread of colistin resistance? Lancet Infect Dis. 2016.pii: S1473-3099(16)00007-4.

  7. García-Fernández A, Carattoli A. Plasmid double locus sequence typing for IncHI2 plasmids, a subtyping scheme for the characterization of IncHI2 plasmids carrying extended-spectrum beta-lactamase and quinolone resistance genes.J Antimicrob Chemother. 2010;65(6):1155-61. DOI: 10.1093/jac/dkq101 PMID: 20356905

  8. Olaitan AO, Chabou S, Okdah L, Morand S, Rolain J-M. Dissemination of the mcr-1 colistin resistance gene.Lancet Infect Dis. 2016;16(2):147. DOI: 10.1016/S1473-3099(15)00540-X PMID: 26711360

  9. Public Health England (PHE). First detection of plasmid-mediated colistin resistance (mcr-1 gene) in food and human isolates in England and Wales (Serial number 2015/090). 2015.

  10. Webb HE, Granier SA, Marault M, Millemann Y, den Bakker HC, Nightingale KK,  et al.  Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis. 2016;16(2):144-5. DOI: 10.1016/S1473-3099(15)00538-1 PMID: 26711363

  11. Agersø Y, Jensen JD, Hasman H, Pedersen K. Spread of extended spectrum cephalosporinase-producing Escherichia coli clones and plasmids from parent animals to broilers and to broiler meat in a production without use of cephalosporins.Foodborne Pathog Dis. 2014;11(9):740-6. DOI: 10.1089/fpd.2014.1742 PMID: 24972048

  12. Mead G. Microbiological quality of poultry meat: a review.Rev Bras Cienc Avic. 2004;6(3):135-42. DOI: 10.1590/S1516-635X2004000300001

  13. Nilsson O, Börjesson S, Landén A, Bengtsson B. Vertical transmission of Escherichia coli carrying plasmid-mediated AmpC (pAmpC) through the broiler production pyramid.J Antimicrob Chemother. 2014;69(6):1497-500. DOI: 10.1093/jac/dku030 PMID: 24550380

  14. Zurfluh K, Wang J, Klumpp J, Nüesch-Inderbinen M, Fanning S, Stephan R. Vertical transmission of highly similar bla CTX-M-1-harboring IncI1 plasmids in Escherichia coli with different MLST types in the poultry production pyramid.Front Microbiol. 2014;5:519. DOI: 10.3389/fmicb.2014.00519 PMID: 25324838

Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.